1-4 of 4
Kishan K Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness of Azacitidine and Ivosidenib in Newly Diagnosed Older, Intensive Chemotherapy-Ineligible Patients with IDH1 -Mutant Acute Myeloid Leukemia

Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory Michael Shallis, Nikolai A. Podoltsev, Maximilian F. Stahl, Jessica M. Stempel, Eytan Stein, Scott F. Huntington, Amer M. Zeidan
Journal: Blood
Blood (2022) 140 (Supplement 1): 319–321.
https://doi.org/10.1182/blood-2022-158465
Published: 2022
Journal Articles

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia

Jan Philipp Bewersdorf, Kishan K. Patel, George Goshua, Rory M. Shallis, Nikolai A. Podoltsev, Scott F. Huntington, Amer M. Zeidan
Journal: Blood
Blood (2022) 139 (11): 1766–1770.
https://doi.org/10.1182/blood.2021014401
Published: 2022
Includes: Supplemental data
Journal Articles

Cost-Effectiveness of Liposomal Cytarabine-Daunorubicin (CPX-351) Compared to Conventional Cytarabine-Daunorubicin Chemotherapy in Acute Myeloid Leukemia

Jan Philipp Bewersdorf, George Goshua, Kishan K Patel, Rory M. Shallis, Nikolai Podoltsev, Scott F. Huntington, Amer M. Zeidan
Journal: Blood
Blood (2021) 138 (Supplement 1): 113.
https://doi.org/10.1182/blood-2021-144992
Published: 2021
Journal Articles

Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemia

Clinical Trials & Observations
Kishan K. Patel, Iris Isufi, Shalin Kothari, Amy J. Davidoff, Cary P. Gross, Scott F. Huntington
Journal: Blood
Blood (2020) 136 (17): 1946–1955.
https://doi.org/10.1182/blood.2020004922
Published: 2020
Includes: Supplemental data